TABLE I.

Comparison of clinical characteristics between wt FLT3 and FLT3ITD patients.

	FLT3ITD		wtFLT3
Patient characteristic	N	Median, Range	N	Median, Range	P value
Age at Diagnosis	9	44(19, 60)	12	41(20, 60)	0.88
Gender (male/female)	9	5/4	13	6/7	1.0
Time to CR1 (months)	9	1.22 (0.89, 1.74)	13	1.27 (0.92, 2.5)	0.89
Hgba	8	10.7.(8.6,12.5)	13	10.7 (5.2, 12.3)	0.49
WBCb	8	16.4 (0.5, 65.7)	13	1.5 (0.5, 7.5)	0.1
Platelet	8	38.5 (9, 123)	13	42 (8, 204)	0.64
PTc (sec)	8	17.8 (10.8, 21.4)	13	14.3 (11.2, 21.4)	0.16
aPTTd (sec)	8	28.3 (22.1, 42.2)	13	27.2 (21.3, 49.9)	0.29
Fibrinogen	8	103.5 (60, 251)	12	235 (62, 381)	0.04
ITD Allelic ratio	9	0.2578 (0.04, 0.85)
ITD length	9	30 (21, 66)

^aHemoglobin;

^bWhite blood count;

^cProthrombin time;

^dActivated partial thromboplastin time.